Vivo Capital, LLC Karuna Therapeutics, Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$62.14 - $117.21 $13.9 Million - $26.2 Million
-223,692 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$60.41 - $115.92 $13.5 Million - $25.9 Million
223,692 New
223,692 $16.1 Million
Q3 2019

Nov 13, 2019
SELL
$16.05 - $27.35 $5.22 Million - $8.89 Million
-325,000 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$20.02 - $20.02 $6.51 Million - $6.51 Million
325,000 New
325,000 $6.51 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email